Technology, Health, Consumer, IT & software · 12 h
14 storiesMFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug
Korea's Ministry of Food and Drug Safety approved Hanmi Pharmaceutical's EPPE auto-injector (efpeglenatide) on Oct 7, the first domestically developed GLP-1 obesity drug and the country's 45th homegrown new drug. The injectable is indicated…
Roszdravnadzor denies shortage of anti-anxiety drug Atarax in Russia
Roszdravnadzor said there are no signs of a shortage of the prescription anti-anxiety drug Atarax in Russia, according to Kommersant, Vedomosti and RBC. The regulator said more than 512,000 Atarax packages are in civil circulation and that …
Nissui logistics unit outage halts shipments at 17 sites; unauthorized access suspected
Nissui said a system failure at its subsidiary Nissui Logistics has stopped inbound and outbound shipments at all 17 of the unit's warehouses. The company believes the cause was unauthorized access by a third party to a data center used by …
Turkey's Aselsan announces Astralink network of 198 low-orbit satellites
Aselsan CEO Ahmet Akyol said at the International Astronautical Congress in Antalya that Turkey is building Astralink, a low-orbit satellite constellation of 198 spacecraft, with the first launch planned within two years. Akyol said work be…
Russia says employee at plague research institute has pneumonia of unknown cause
Russia's consumer rights and public health watchdog said a sick employee of the Siberia and Far East Plague Control Research Institute in Irkutsk was diagnosed with “pneumonia of unknown cause”, after online rumours that a staff member had …
Kremlin: Russia informed WHO of Irkutsk region situation after worker death
Kremlin spokesman Dmitry Peskov said Russia has informed the World Health Organization about the situation in the Irkutsk region, following the death of an employee of the Irkutsk anti-plague institute. Peskov also said he had no informatio…
Moscow SEZ resident Angstrom develops Russian chip for linking electronic devices
Angstrom, a resident of the Technopolis Moscow special economic zone, has developed a microchip for data transmission between electronic devices, according to the company and the zone’s representatives. The chip is built on the RS-485 indus…
Musk says his companies will build and run Terafab chip plant, rules out TSMC role
Elon Musk said on Oct. 7 that his companies will independently build and operate the Terafab chip manufacturing project in Texas, ruling out an operational role for TSMC. He said TSMC could lease part of the planned site or capacity if inte…
Russia's Interior Ministry says Telegram refuses to cooperate on drug propaganda
Russia's Interior Ministry said Telegram is not responding to its offers of contact in the fight against drug propaganda, with the acting head of its drug-control directorate, Kirill Smurov, saying the messenger is used to draw teenagers in…
Xreal opens pre-orders for Android XR Aura smartglasses from $1,279
Xreal has opened pre-orders for the Aura, its Android XR smartglasses announced earlier this year at Google I/O, starting at $1,279 for a 12GB RAM / 256GB storage model and $1,499 for a 16GB / 512GB version. The glasses are tethered to a co…
Ring announces first smart lock with a hand crank for dead batteries
Amazon-owned Ring announced its first smart lock, which uses a hand-cranked dial to generate enough power to open the door when its rechargeable battery is dead. The company said the lock will cost $249, come in black, silver and brass, and…
WHO says more than 170 million children and adolescents worldwide live with obesity
The World Health Organization says more than 170 million children and adolescents aged 5 to 19 worldwide have been diagnosed with obesity, with prevalence in that age group rising fourfold since 1990, from 2% to about 8%. The WHO issued gui…
Panasonic plans to start making humanoid robots for factories and warehouses by 2029
Panasonic Holdings plans to begin producing humanoid robots by 2029, for use on production lines and in warehouses, the company’s AI director Akira Sakakibara said in an interview with Nikkei. Work is already under way at the company’s AI &…
Betta Pharmaceuticals unit's BPI-572270 capsule wins US FDA clinical trial clearance
Betta Pharmaceuticals said the US FDA has approved a clinical trial application for BPI-572270 capsules, filed by its wholly-owned subsidiary Jingyao Biology, for advanced solid tumours. The company described the drug as a self-developed pa…